Cell-seeded porous lung hydrogel sealant
US-2019224364-A1 · Jul 25, 2019 · US
US9446166B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9446166-B2 |
| Application number | US-201313748678-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 24, 2013 |
| Priority date | Jan 24, 2013 |
| Publication date | Sep 20, 2016 |
| Grant date | Sep 20, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention relates to tissue adhesives or sealants, more specifically to fibrinogen based sealants reinforced with particulate material and chemically cross-linked. More particularly, the present invention is directed to tissue sealant, adhesive, hemostat, or scaffolding material containing thrombin, fibrinogen, a biocompatible particulate material having amine functionality, and a biocompatible polymer containing aldehyde groups. The present invention is also directed to methods for the use of such materials.
Opening claim text (preview).
I claim: 1. A tissue sealant, adhesive, hemostat, or scaffolding material, wherein said tissue sealant, adhesive, hemostat, or scaffolding material is a two-part system comprising a first solution and a second solution, comprising: thrombin, fibrinogen, a biocompatible particulate material having amine functionality, said biocompatible particulate material is atelocollagen a biocompatible polymer containing aldehyde groups, wherein said biocompatible polymer is oxidized dextran or polyvinyl alcohol acetoacetate; and a catalyst, wherein said first solution comprises thrombin, biocompatible particulate material, and the biocompatible polymer; wherein said second solution comprises fibrinogen and the catalyst; and wherein said catalyst is DABCO. 2. The tissue sealant, adhesive, hemostat, or scaffolding material of claim 1 , wherein the biocompatible polymer containing aldehyde groups is oxidized dextran. 3. The tissue sealant, adhesive, hemostat, or scaffolding material of claim 2 , wherein the biocompatible particulate material is atelocollagen, and wherein the biocompatible polymer containing aldehyde groups is oxidized dextran. 4. The tissue sealant, adhesive, hemostat, or scaffolding material of claim 3 , wherein said first solution comprises thrombin, atelocollagen, and oxidized dextran and wherein said second solution comprises fibrinogen and DABCO. 5. The tissue sealant, adhesive, hemostat, or scaffolding material of claim 4 , wherein concentration of atelocollagen is about 2%; particle size of atelocollagen is less than 100 micron; concentration of oxidized dextran is about 10% by volume, and the molecular weight of oxidized dextran is between about 10,000 and 100,000. 6. The tissue sealant, adhesive, hemostat, or scaffolding material of claim 5 , wherein said first solution and said second solution are sprayed substantially simultaneously or sequentially on the tissue to form sealant, adhesive, hemostat, or scaffolding.
containing macromolecular fillers · CPC title
Dextran; Derivatives thereof · CPC title
Compositions of proteins; Compositions of derivatives thereof (foodstuff preparations A23J3/00) · CPC title
derived from leather or skin {, e.g. gelatin} · CPC title
Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.